Fluoxetine (Prozac)

Introduced 1987

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published February 6, 2026•Updated February 6, 2026•Reviewed February 6, 2026

Clinical summary for Fluoxetine (Prozac): Fluoxetine (Prozac) is an SSRI that slowly helps reset brain chemistry for depression, anxiety, OCD, panic, bulimia, and PMDD. You don’t feel it right away—most people notice a shift over 2–6 weeks. The big pros: better mood, less worry, fewer obsessive loops or panic attacks. The tradeoffs: nausea, sleep changes, sexual side effects, and in younger people a small but real increase in suicidal thoughts early on—so close monitoring is non-negotiable.

What It’s Used For

Fluoxetine is a workhorse SSRI for mood and anxiety conditions. It’s not a rescue med—it’s a daily baseline medication that slowly resets serotonin signaling over weeks.

Primary Indications

Major Depressive Disorder (MDD): First-line SSRI option in many adults, teens, and kids ≥8.Obsessive-Compulsive Disorder (OCD): Helps dial down obsessive loops and compulsive rituals, often at higher doses.Panic Disorder: Reduces frequency and intensity of panic attacks over time.Bulimia Nervosa: Targets binge–purge cycles and underlying mood/anxiety symptoms.Premenstrual Dysphoric Disorder (PMDD): Reduces severe mood swings and irritability tied to the luteal phase.Bipolar I Depression: Used only together with a mood stabilizer or antipsychotic—never alone.Generalized Anxiety Disorder (GAD): Off-label option when chronic worry and physical tension are front and center.Posttraumatic Stress Disorder (PTSD): Off-label SSRI option alongside trauma therapy.Social Anxiety Disorder: Off-label option for chronic social fear/avoidance.Selective mutism, anorexia nervosa (weight-restored phase), and binge eating disorder: off-label and typically specialist-managed.

Off-Label Uses

Generalized anxiety disorderSocial anxiety disorderPosttraumatic stress disorderBody dysmorphic disorderBinge eating disorderFibromyalgia (refractory cases)Premature ejaculationSelective mutism in children

What People Commonly Notice

Fluoxetine is more of a slow internal shift than a dramatic "wow" moment. Here’s how people often describe it:

First Few Weeks (1–3)

"The first week I mostly felt wired and a little nauseous."

How Fast It Works (And How Long It Lasts)

Fluoxetine is the opposite of a quick fix. It quietly builds up in your system and its active metabolite hangs around for weeks.

Depression

Some people feel a shift in energy or sleep in 1–2 weeks; fuller mood benefit usually takes 4–6 weeks (sometimes longer).

Anxiety disorders (GAD, panic, OCD, PTSD)

Early improvement may appear by 2 weeks, but a solid trial is 6–12 weeks at a therapeutic dose.

OCD and body dysmorphic disorder

Often need 10–12+ weeks, including time at higher doses, before judging benefit.

PMDD

Many people feel a difference in the first treated cycle; some notice benefit within days of starting luteal or symptom-onset dosing.

Long half-life

Fluoxetine and norfluoxetine can remain in the body for weeks—effects and side effects may linger even after stopping.

Withdrawal

Because of the long half-life, classic SSRI discontinuation symptoms are less intense than with short-acting agents, but relapse of underlying symptoms can still occur.

How Well It Works

Clinical response in depression at 6–8 weeks

≈50–60% response

vs ≈30–35% response with placebo

Across multiple randomized trials, fluoxetine improves depressive symptoms in about half of patients within 6–8 weeks, outperforming placebo by a meaningful margin. The effect is even more robust when combined with psychotherapy and lifestyle work (sleep, movement, structure). For anxiety disorders, OCD, and bulimia, response often requires higher doses and longer trials, but benefits can be substantial when patients can tolerate the medication and stay with it.

Critical Safety Information

Like all antidepressants, fluoxetine carries a black box warning for increased suicidal thoughts and behaviors in children, adolescents, and young adults.

→If you or someone close to you notices worsening depression, new or increased suicidal thoughts, extreme irritability, or sudden behavior changes—contact your prescriber urgently or go to emergency care.
→Never combine fluoxetine with an MAOI and don’t start an MAOI until at least 5 weeks after stopping fluoxetine.
→Tell your prescriber about ALL meds and supplements—especially other antidepressants, migraine meds, tramadol, St. John’s wort, and illicit substances.
→Report severe restlessness, feeling like you “can’t sit still,” or new manic symptoms (racing thoughts, less need for sleep, risky behavior).
→Watch for signs of bleeding (bruises, nosebleeds, dark stools) if you take NSAIDs, aspirin, or blood thinners.
→Do not stop fluoxetine suddenly without a plan—always talk to your prescriber about tapering and timing.

Side Effects

Most side effects are dose-related and show up in the first few weeks—especially GI upset, sleep changes, activation, and sexual dysfunction. Some rare effects (bleeding, hyponatremia, rash, arrhythmia) require immediate attention.

Common Things People Notice

Nausea, diarrhea, or upset stomach—often improve with food, time, or dose adjustment.
Trouble falling or staying asleep, vivid dreams, or early morning waking.
Feeling jittery, restless, or more anxious at first (especially in panic and GAD).
Headache, sweating, and mild tremor.
Sexual side effects: lower libido, delayed orgasm, difficulty with arousal or erections.
Small weight changes (often mild weight loss early on).
Less common but serious: severe rash, eye pain/vision changes, confusion, seizures, or signs of bleeding.

Common Side Effects

Very common (10–30%)

GI upset (nausea, diarrhea, dry mouth)— Usually shows up early and improves over 1–3 weeks. Taking with food, starting lower, and slowing titration can help. Persistent vomiting, black stools, or blood in stool is NOT typical—seek care.

10–30%

Insomnia or sleep disruption— Can cause lighter sleep, early waking, or more vivid dreams. Morning dosing and a steady sleep routine usually help. If it’s brutal, the dose or timing may need adjusting.

Up to ~15%, higher in anxiety disorders and youth

Activation (restlessness, jitteriness, anxiety flare)— You might feel a bit more wired before things settle. This doesn’t mean the med is wrong, but if you feel like you’re “crawling out of your skin” or getting panic attacks, call your prescriber.

Very common; often underreported

Sexual dysfunction (low libido, delayed orgasm, anorgasmia, erectile issues)— This is a real and common effect—not in your head and not a character flaw. For some, it’s a tradeoff they accept; others try dose tweaks, timing adjustments, or med changes.

5–15%

Sweating, tremor, and yawning— Mild sweating, fine tremor, and lots of yawning are classic SSRI side effects. They’re usually benign but can be annoying; dose adjustments often help.

Low to moderate; often small changes

Weight changes— Fluoxetine tends to be a little weight-neutral or mildly weight-reducing early on. Big, rapid weight changes should be evaluated for other causes.

⚠️ Serious Side Effects

Serotonin syndrome: agitation, confusion, sweating, fever, tremor, muscle rigidity, diarrhea, and unstable vital signs—especially with other serotonergic meds. This is an emergency.
Severe skin reactions: blistering rash, peeling skin, mucosal involvement (mouth, eyes, genitals) can signal Stevens–Johnson syndrome or toxic epidermal necrolysis—seek emergency care.
Hyponatremia/SIADH: confusion, headaches, nausea, falls, seizures—most often in older adults or those on diuretics.
Bleeding: black or bloody stools, vomiting blood, frequent nosebleeds, or unusual bruising—especially with NSAIDs, aspirin, or anticoagulants.
QT prolongation and arrhythmias: palpitations, fainting, or unexplained dizziness—higher risk with other QT-prolonging drugs or electrolyte problems.
Mania/hypomania: decreased need for sleep, racing thoughts, risky behavior, irritability—especially in those with bipolar vulnerability.
Seizures: rare, but risk is higher in those with seizure disorders or heavy alcohol use.
Acute angle-closure glaucoma: sudden eye pain, vision changes, halos around lights—requires urgent ophthalmologic care.

Important Drug Interactions

Fluoxetine is both a serotonergic drug and a strong CYP2D6 inhibitor with a long half-life. Interactions can linger for weeks after you stop it.

With: MAOIs (phenelzine, tranylcypromine, selegiline, isocarboxazid) and linezolid/methylene blue

Risk: High risk of serotonin syndrome—can be life-threatening.

Action: Do NOT combine. Wait at least 14 days after stopping an MAOI before starting fluoxetine, and at least 5 weeks after stopping fluoxetine before starting an MAOI.

With: Other serotonergic drugs (SSRIs, SNRIs, TCAs, triptans, tramadol, lithium, St. John’s wort, MDMA, certain opioids)

Risk: Additive serotonergic effect and higher risk of serotonin syndrome.

Action: Avoid unnecessary combinations; if combination is clinically needed, use lowest effective doses and monitor closely for serotonin toxicity.

With: Antiplatelets, anticoagulants, NSAIDs (aspirin, ibuprofen, clopidogrel, warfarin, DOACs)

Risk: Increased risk of GI and other bleeding.

Action: Use caution. Consider GI protection in high-risk patients, monitor for bleeding signs, and ensure prescribers coordinating care know about all agents.

With: QT-prolonging drugs (certain antipsychotics, methadone, some antibiotics, antiarrhythmics)

Risk: Additive QT prolongation and possible torsades de pointes.

Action: Avoid high-risk combinations when possible; if necessary, correct electrolytes, consider baseline and follow-up ECGs, and use the lowest reasonable doses.

With: CYP2D6 substrates (e.g., some TCAs, antipsychotics, beta blockers, tamoxifen)

Risk: Fluoxetine strongly inhibits CYP2D6, increasing serum levels of some drugs and potentially reducing activation of others (e.g., tamoxifen).

Action: Check for interactions before combining. You may need dose adjustments or a different antidepressant that doesn’t inhibit CYP2D6.

With: Alcohol and sedatives

Risk: Increased sedation, cognitive impairment, and fall risk (though fluoxetine by itself is usually not strongly sedating).

Action: Limit or avoid alcohol. Use caution with benzodiazepines, sleep meds, or other sedatives, especially in older adults.

Stopping Fluoxetine Safely

Because fluoxetine and its metabolite stick around for a long time, withdrawal symptoms are less dramatic than with short-acting SSRIs—but that doesn’t mean you can just vanish it without a plan.

Key Points

Discuss timing: Try to taper during a relatively stable, lower-stress period when possible.
Typical taper: For many adults, decreasing the dose by about 10–25% every 2–4 weeks works well. Go slower if symptoms flare.
Long-term use: After years of treatment or at higher doses, many people benefit from a very gradual taper over several months.
Watch for relapse vs withdrawal: Worsening depression/anxiety over weeks often signals relapse; brief brain zaps, dizziness, or irritability right after dose drops may be more withdrawal-like.
Don’t rush after remission: Guidelines often recommend continuing treatment for at least 6–12 months after full symptom remission (longer after multiple episodes).
Never stop alone: If discontinuation symptoms or depressive symptoms get intense, it’s okay to pause the taper, bump back up slightly, and slow things down with your prescriber’s help.

Dosing Information (Psychiatry-Focused, Not Prescribing Instructions)

Adult Dosing

mdd initial: 10–20 mg PO once daily, usually in the morning.

mdd titration: Increase by 10–20 mg/day every 1–2 weeks based on response and side effects.

mdd usual: 20–40 mg/day; some patients benefit from 60 mg/day.

mdd max: Up to 80 mg/day in select cases under specialist supervision.

ocd initial: 10–20 mg PO once daily; start lower (10 mg) in anxious or sensitive patients.

ocd range: Common target range 40–80 mg/day; some highly refractory cases may go higher if tolerated.

panic initial: 5–10 mg PO once daily; start low to avoid activation.

panic titration: Increase by 5–10 mg/day every 1–2 weeks as tolerated.

panic range: Typical effective range 20–40 mg/day; some patients up to 60 mg/day.

gad initial: 10–20 mg PO once daily.

gad range: Often 20–40 mg/day; up to 60 mg/day in more severe cases.

ptsd initial: 10–20 mg PO once daily.

ptsd range: Usual range 20–60 mg/day; up to 80 mg/day in select cases.

social anxiety initial: 10–20 mg PO once daily.

social anxiety range: Typical range 20–40 mg/day; can go to 60 mg/day if tolerated.

bulimia target: Target dose around 60 mg/day PO once daily, often after a brief titration upward.

pmdd continuous: 10 mg/day PO, increasing to 20 mg/day after ~1 cycle if needed; some patients use 30 mg/day.

pmdd luteal: 10–20 mg/day PO during the luteal phase only (about 14 days before menses until onset of bleeding); some increase to 30 mg/day in later cycles.

pmdd symptom onset: 10–20 mg/day PO starting at first PMDD symptom and continuing until a few days after onset of menses.

bipolar depression combo: Typically 20 mg/day PO in the evening combined with an antipsychotic such as olanzapine, with cautious titration; never used alone in bipolar I.

weekly formulation: Once stabilized on 20 mg/day, some adults may switch to 90 mg PO once weekly delayed-release as a maintenance strategy.

Simple Explanation

Fluoxetine is usually taken once daily. Most people start low and slowly climb to a dose that reduces symptoms without intolerable side effects. Higher doses are often needed for OCD, bulimia, and body dysmorphic disorder. Because the drug and its metabolite hang around for days to weeks, missed doses and dose changes are smoother than with shorter-acting SSRIs—but that also means interactions and side effects fade slowly.

Pregnancy, Breastfeeding, Kids, Older Adults, and Organ Disease

Fluoxetine is often used across the lifespan, but the risk–benefit calculation changes with pregnancy, age, liver disease, and other factors.

👶Pregnancy

Fluoxetine and norfluoxetine cross the placenta. Overall, data do not show a major increase in overall birth defects, though some studies suggest a small possible increase in cardiac malformations that hasn’t been clearly proven. Late-pregnancy exposure can lead to neonatal adaptation syndrome (irritability, jitteriness, feeding problems, breathing changes) and rarely persistent pulmonary hypertension of the newborn. Stopping abruptly in pregnancy can trigger relapse of depression or anxiety, which itself carries risks (preterm birth, low birth weight, postpartum depression). In practice, SSRIs are usually continued if they are clearly helping; fluoxetine is not typically the first SSRI chosen in treatment-naïve pregnant patients, but continuation is often reasonable if the patient is stable.

🤱Breastfeeding

Fluoxetine and norfluoxetine are present in breast milk and sometimes reach relatively higher infant levels than some other SSRIs. Most infants do fine, but there are case reports of irritability, poor feeding, and poor weight gain. If fluoxetine is the only med that has worked well, many clinicians will continue it while breastfeeding with close monitoring of infant weight, feeding, sleep, and behavior. For someone starting an SSRI for the first time while breastfeeding, other SSRIs with lower milk transfer are often preferred.

👧Children & Adolescents (Under 18)

Fluoxetine is FDA-approved for MDD in children ≥8 and OCD in children ≥7, and widely used off-label for pediatric anxiety disorders. Kids are more prone to activation (agitation, restlessness, sleep disruption) and suicidal thinking early on, so careful monitoring and family involvement are essential. Dosing starts very low (often 5–10 mg/day) and titrates slowly.

👴Older Adults (65+)

Older adults are more vulnerable to hyponatremia, falls, bleeding, and drug interactions. The long half-life is a double-edged sword: it smooths missed doses but can cause prolonged side effects and interactions. Start low, go slow, monitor sodium, falls, and cognitive changes, and re-evaluate often.

🔬Liver Impairment

Fluoxetine clearance is reduced and half-life prolonged in liver impairment. Many clinicians start at lower doses and use a lower ceiling (e.g., not exceeding ~40 mg/day or 50% of the usual max), with slow titration and close monitoring. Long half-life plus cirrhosis can lead to accumulation.

💧Kidney Impairment

No routine dose adjustment is typically needed in kidney impairment, and fluoxetine is not significantly removed by dialysis. However, chronic severe kidney disease can alter pharmacokinetics, so watch closely for side effects and consider lower doses if sensitivity is evident.

Monitoring in Real Life

Mood and suicidality: Track depressive symptoms, anxiety, and suicidal thoughts weekly early on, then at each visit. This is especially critical for children, adolescents, and young adults.
Behavioral activation and akathisia: Watch for intense restlessness, pacing, or feeling like you "can’t sit still"—this can drive distress and suicidality.
Mania/hypomania: Screen at baseline and monitor for new elevated mood, decreased need for sleep, grandiosity, or risky behavior.
Serum sodium: Check in older adults, those on diuretics, and anyone with prior hyponatremia or unexplained confusion/falls.
Bleeding: Ask about bruising, nosebleeds, black stools, heavy menstrual bleeding, especially in patients on NSAIDs or anticoagulants.
Cardiac risk: Consider baseline and periodically follow-up ECG in patients with known heart disease, electrolyte disturbances, or other QT-prolonging drugs.
Weight, appetite, and sleep: Track changes over time; adjust dosing time and sleep hygiene as needed.
Liver function: Baseline and periodic checks in patients with known liver disease or on other hepatotoxic meds.
Medication interactions: Re-review all meds and supplements at each significant dose change; fluoxetine’s CYP2D6 inhibition and long half-life make this crucial.
Function: Look beyond symptom scores—ask about school, work, relationships, and basic self-care to gauge real-world benefit.

Available Formulations

Immediate-release capsules: 10 mg, 20 mg, 40 mg (US generics; similar strengths in Canada).
Immediate-release tablets: 10 mg, 20 mg, 60 mg (various generics; PMDD branding historically used for some strengths).
Oral solution: 20 mg/5 mL, useful for fine-tuning doses or in patients who can’t swallow pills.
Delayed-release (once-weekly) capsule: 90 mg, typically used after stabilization on 20 mg/day.

How It Works in the Brain

Fluoxetine blocks the reuptake of serotonin (5-HT) into neurons, leaving more serotonin available in the synaptic space. Over time, this triggers adaptive changes in serotonin receptors and downstream signaling pathways that help stabilize mood, reduce anxiety, and quiet obsessive loops. It has minimal direct effect on norepinephrine or dopamine reuptake and doesn’t significantly bind histamine, muscarinic, or alpha-adrenergic receptors—which is why it’s usually less sedating and less anticholinergic than older antidepressants.

Where Fluoxetine Fits in Treatment Plans

In modern psychiatry, fluoxetine is a foundational SSRI with a long track record, especially in adolescents and young adults. It’s often a first-line choice for depression and OCD in youth and a reasonable option for adults who prefer a slightly more activating, longer-half-life SSRI. Its long half-life is a blessing for missed doses and withdrawal, but a curse when side effects or interactions appear. It’s rarely the best choice for someone who needs a very quick change (e.g., severe acute suicidality) without strong support, but it’s excellent as a steady, background antidepressant–anxiolytic once the patient is engaged in treatment and follow-up.

Frequently Asked Questions

What is fluoxetine (Prozac) used for in mental health?

Fluoxetine is an SSRI antidepressant used to treat major depression, OCD, panic disorder, bulimia nervosa, and PMDD. It’s also commonly used off label for generalized anxiety disorder, social anxiety, PTSD, and some eating and body image conditions. It’s a daily med meant to stabilize mood and anxiety over time, not a fast-acting rescue pill.

How long does it take for fluoxetine to start working?

Most people don’t feel much in the first few days. You might notice subtle changes in sleep, energy, or appetite in 1–2 weeks. Mood and anxiety benefits usually show up between weeks 2 and 6, sometimes later. OCD, bulimia, and body dysmorphic disorder often need higher doses and at least 10–12 weeks before you really know how helpful it is.

Why does fluoxetine have a suicidality warning?

In short-term studies, kids, teens, and young adults taking antidepressants—including fluoxetine—had a small increase in suicidal thoughts and behaviors compared to placebo. Adults over 24 did not show this increased risk, and adults 65+ actually had a lower risk on antidepressants than on placebo. Because depression itself is a major risk factor for suicide, we don’t avoid treatment—we monitor closely, especially in the first few months and after dose changes, and involve family or trusted supports in the safety plan.

Is fluoxetine more activating or sedating?

Compared with some other SSRIs, fluoxetine leans a bit more activating. That can be great in low-energy, slowed-down depression, but tricky if your main issue is agitation, insomnia, or panic. Many people do fine with morning dosing; if you feel wired or jittery, talk with your prescriber about dose, timing, or whether a different SSRI might fit better.

What are the most common side effects of fluoxetine?

The big ones: nausea or loose stools, sleep changes (usually insomnia or vivid dreams), increased anxiety or restlessness at first, headaches, sweating, and sexual side effects (low libido, delayed orgasm, difficulty with erections or arousal). These are often dose-related and may improve with time or dose adjustments. Serious side effects like severe rash, bleeding, eye pain, or signs of serotonin syndrome are rare but need urgent evaluation.

Does fluoxetine cause weight gain?

Fluoxetine is generally weight-neutral or mildly weight-reducing for many people, especially early in treatment. That said, weight can still drift up or down over time due to mood, appetite, energy, and lifestyle shifts. Big or rapid weight changes deserve a closer look for other medical or medication-related causes.

Can fluoxetine affect sex drive or orgasm?

Yes. Sexual side effects are common with SSRIs, and fluoxetine is no exception. People often report lower libido, trouble with arousal, delayed orgasm, or anorgasmia. Some men notice delayed ejaculation or improved premature ejaculation at the cost of overall desire. If sex is important to you (spoiler: it usually is), this should be part of the treatment conversation from the start. There are strategies—dose adjustments, timing, or sometimes med changes—that can help.

Is fluoxetine safe in pregnancy and breastfeeding?

There’s no zero-risk option, including “no treatment.” Fluoxetine has been studied extensively in pregnancy. Overall, it doesn’t show a big increase in overall birth defects, though there may be a small, not-fully-proven increase in certain cardiac malformations. Late-pregnancy exposure can cause neonatal adaptation symptoms and rarely persistent pulmonary hypertension of the newborn. For breastfeeding, fluoxetine and its metabolite do enter breast milk and infant blood, sometimes at higher levels than with other SSRIs, but many infants do well with good monitoring. Whether to continue, switch, or start fluoxetine during pregnancy or breastfeeding is a shared decision between you and your clinician that balances symptom severity, past treatment history, and your preferences.

Does fluoxetine cause withdrawal if I stop it?

Compared with short-acting SSRIs like paroxetine, fluoxetine has a much lower risk of classic “brain zap” withdrawal because its levels fall very slowly. But stopping abruptly—especially after long-term use—can still trigger mood dips, irritability, or anxiety relapse. A gradual taper over weeks to months, with close monitoring, is still the safest approach.

Can I drink alcohol while taking fluoxetine?

Alcohol plus any psych med is generally a bad combo, even if it’s not absolutely forbidden the way it is with benzos or some sedatives. Alcohol can worsen depression and anxiety, blunt the benefits of fluoxetine, increase sedation or disinhibition, and raise the risk of falls or accidents. If you drink, keep it light, predictable, and talk openly with your clinician about your use.

How long do I need to stay on fluoxetine?

For a first episode of depression or anxiety that responds well, many guidelines suggest staying on the medication for at least 6–12 months after you feel fully better to reduce relapse risk. After multiple episodes, strong family history, or more severe illness, longer maintenance (several years or more) may be recommended. This should be a recurring conversation—not a lifetime sentence decided at your first visit.

What’s the difference between fluoxetine and other SSRIs like sertraline or escitalopram?

All SSRIs increase serotonin, but they differ in half-life, activation, interactions, and side-effect profile. Fluoxetine is more activating, has a very long half-life, and strongly inhibits CYP2D6, which matters if you’re on certain other meds (like some antipsychotics, TCAs, or tamoxifen). Sertraline is often favored in pregnancy and PTSD; escitalopram is popular for its relatively clean, gentle feel. The “right” SSRI is more about your brain, body, comorbidities, and meds than about brand names.

This medication information is for educational purposes only and is not a substitute for professional medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication. Never take medication without a prescription from a licensed healthcare provider.

Interested in this treatment?

This information is for educational purposes. Always consult with a qualified healthcare provider before starting any new treatment.

Locate Psychiatrists

Fluoxetine (Prozac)

Introduced 1987

Reviewed by the HeyPsych Medical Review Board

Board-certified psychiatrists and mental health professionals

Published February 6, 2026•Updated February 6, 2026•Reviewed February 6, 2026